• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY COSTA RICA S.R.L. ORBERA INTRA GASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY COSTA RICA S.R.L. ORBERA INTRA GASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
I am physician and undergone an intra gastric balloon placement in (b)(6) 2022.Few month after placement i felt hard bulging area in my abdomen.I was told it is balloon that turned palpable after losing some weight.After balloon removal in (b)(6) 2022.The mass was there and after study it was diagnosed malignant sarcoma.Now this sarcoma metastasized to my lungs and abdomen.I underwent surgery in (b)(6) 2022 and i am receiving chemo.The instruction for product not recommending any imaging before or during placement which can mask intra abdominal tumor.In my case if this tumor diagnosed earlier i had a better chance to fight it.This product really took away my chance to timely diagnosis of my intra abdominal tumor and significantly deteriorated my prognosis.My name is (b)(6) and my cell is (b)(6).My medical record is available as per request.Best regards.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRA GASTRIC BALLOON
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
APOLLO ENDOSURGERY COSTA RICA S.R.L.
MDR Report Key16312947
MDR Text Key309052609
Report NumberMW5114745
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Disability; Other; Required Intervention;
Patient Age54 YR
Patient SexMale
Patient Weight107 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-